The study examined infections identified with MRSA cultures from nine metropolitan areas in the U.S. between 2005 and 2011, classifying cases as healthcare-associated community-onset infections, hospital-onset infections and community-associated infections and noting decreases in hospital-onset and hospital-associated infections between the beginning and end of the data analysis period.
All told, the 2011 estimate for MRSA infections, nearly 80,500, was approximately 30,800 lower than the estimated number of 2005 MRSA infections.
As community-associated infections decreased only 5 percent, the study concluded interventions for community-associated MRSA will have the greatest impact on preventing national MRSA infection rates. In 2011, community-associated MRSA cases accounted for approximately 21 percent of total MRSA cases for that year.
More Articles on MRSA:
‘Winnable Battles’ From CDC Shows Reduced HAIs, Still Room for Improvement
Study: 4 Factors Predict MRSA Colonization Risk
MRSA Declines With 5-Year Bundle VA Intervention
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
